High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma

Niklas Klümper1, Alexander Cox2, Markus Eckstein3

  • 1Department of Urology, University Hospital Bonn (UKB), Bonn, Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany; Institute of Experimental Oncology, University Hospital Bonn (UKB), Bonn, Germany.

European Journal of Cancer (Oxford, England : 1990)
|May 4, 2024
PubMed
Abstract

Insights

Elevated serum sodium levels predict a better response to immune checkpoint inhibition (ICI) in metastatic renal cell carcinoma and urothelial carcinoma. This simple blood test may serve as a cost-effective biomarker for immunotherapy efficacy.

Area of Science:

  • Oncology
  • Immunotherapy
  • Biomarker Discovery

Background:

  • Predicting response to immune checkpoint inhibition (ICI) in metastatic renal cell carcinoma (mRCC) and urothelial carcinoma (mUC) is challenging.
  • Current biomarkers like PD-L1 focus on tumor factors, neglecting other potential predictors.
  • Serum electrolyte levels have been largely unexplored as predictive biomarkers for ICI response.

Purpose of the Study:

  • To evaluate the prognostic and predictive value of baseline serum electrolyte levels (sodium, potassium, chloride, magnesium, calcium) in patients with mRCC and mUC treated with ICI.
  • To compare the efficacy of serum electrolytes as biomarkers against conventional markers like PD-L1 expression.

Main Methods:

  • Post-hoc analysis of serum electrolyte levels from two independent phase 3 clinical trials (IMvigor211 and IMmotion151).
  • Analysis included 1787 patients with mRCC and mUC.
  • Prognostic and predictive values were assessed using multivariate analysis.

Main Results:

  • Baseline serum sodium and chloride levels showed a linear correlation with prognosis in both trials.
  • Elevated serum sodium (>140 mmol/L) was associated with a significantly higher objective response rate to ICI.
  • Serum sodium outperformed PD-L1 expression in predicting immunotherapy efficacy.

Conclusions:

  • Elevated baseline serum sodium levels are associated with superior outcomes in patients receiving immunotherapy.
  • Serum sodium concentration represents a promising, cost-effective predictive biomarker for immunotherapy response across different cancer types.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.